Clinical Research Directory
Browse clinical research sites, groups, and studies.
"Effect of Screening Using Imaging (CT/ EUS) on Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in Patients With New Onset Diabetes (NOD)" - A Prospective Pilot Observational Study
Sponsor: Asian Institute of Gastroenterology, India
Summary
To assess whether EUS (Endoscopic Ultrasound) can serve as a valuable diagnostic tool for identifying PDAC at an early stage in individuals who have recently been diagnosed with diabetes. Purpose: To improve the rates of early detection of pancreatic cancer. Pancreatic ductal adenocarcinoma (PDAC) is a type of cancer that starts in the pancreas, a gland located in your abdomen. It happens when some cells in the pancreas start growing abnormally and form a cancer.
Key Details
Gender
All
Age Range
50 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2023-12-01
Completion Date
2027-09-01
Last Updated
2023-10-24
Healthy Volunteers
No
Conditions
Interventions
A blood sample for CA 19-9 (cancer detection test)
* A blood sample for CA 19-9 (cancer detection test) levels will be taken at baseline. * Contrast CT abdomen - Pancreas protocol will be done at baseline. * EUS (Endoscopic Ultrasound) under moderate sedation will be done at baseline to you. * If suspicious lesion is found on examination, Fine Needle Aspiration - FNA will be done.